UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 345

Sortiert nach

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Annals of oncology, 2013-09, Vol.24 (9), p.2278-2284

2013

Volltextzugriff (PDF)

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

The lancet oncology, 2019-05, Vol.20 (5), p.663-673

2019

Volltextzugriff (PDF)

A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection

Annals of oncology, 2011-09, Vol.22 (9), p.2042-2048

2011

Volltextzugriff (PDF)

Preventing oral mucositis by using its chronology in prior cycle and a special mouthwash

Annals of oncology, 2019-07, Vol.30, p.iv66-iv67

2019

Volltextzugriff (PDF)

Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

Journal of clinical oncology, 2002-04, Vol.20 (8), p.1996-2004

2002

Volltextzugriff (PDF)

Comparing cancer mortality and GDP health expenditure in England and Wales with other major developed countries from 1979 to 2006

British journal of cancer, 2011-11, Vol.105 (11), p.1788-1794

2011

Volltextzugriff (PDF)

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

The Lancet (British edition), 1998-10, Vol.352 (9138), p.1413-1418

1998

Volltextzugriff (PDF)

Longitudinal study of energy and macronutrient intake during the first year following treatment for early stage breast cancer

Proceedings of the Nutrition Society, 2018, Vol.77 (OCE1), Article E10

2018

Volltextzugriff (PDF)

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial

Annals of oncology, 2017-08, Vol.28 (8), p.1817-1824

2017

Volltextzugriff (PDF)

Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1336-1343

2001

Volltextzugriff (PDF)

Prospective DPYD testing in colorectal cancer patients in a realworld UK population

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii187

2018

Volltextzugriff (PDF)

Postoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin benefit in stage II colon cancer (CC): Post hoc analysis of the MOSAIC trial

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii154

2018

Volltextzugriff (PDF)

Glucose Intolerance During Adjuvant Chemotherapy for Breast Cancer

JNCI : Journal of the National Cancer Institute, 2009-04, Vol.101 (7), p.537-537

2009

Volltextzugriff (PDF)

Modulation of platelet levels by an anti-IL-1α antibody (MABp1) in advanced colorectal cancer patients

European journal of cancer (1990), 2017-02, Vol.72, p.S70-S70

2017

Volltextzugriff (PDF)

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF

British journal of cancer, 2005-06, Vol.92 (11), p.1976-1983

2005

Volltextzugriff (PDF)

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

Annals of oncology, 2005-04, Vol.16 (4), p.549-557

2005

Volltextzugriff (PDF)

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women

Journal of clinical oncology, 1996-01, Vol.14 (1), p.78-84

1996

Volltextzugriff (PDF)

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

Journal of clinical oncology, 1997-01, Vol.15 (1), p.261-267

1997

Volltextzugriff (PDF)

The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four randomised controlled trials

Annals of oncology, 2009-05, Vol.20 (5), p.885-891

2009

Volltextzugriff (PDF)

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

Annals of oncology, 1998-11, Vol.9 (11), p.1179-1184

1998

Volltextzugriff (PDF)

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

British Journal of Cancer, 1999-04, Vol.80 (1-2), p.269-272

1999

Volltextzugriff (PDF)

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

Journal of clinical oncology, 1995-03, Vol.13 (3), p.547-552

1995

Volltextzugriff (PDF)

Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials

European journal of cancer (1990), 2006-05, Vol.42 (7), p.827-834

2006

Volltextzugriff (PDF)

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

Journal of clinical oncology, 1996-03, Vol.14 (3), p.700-708

1996

Volltextzugriff (PDF)

1 – 25 von 345

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(301)
Mit Volltextzugriff
(319)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(345)
Japanisch
(19)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Humans
(172)
Life Sciences & Biomedicine
(150)
Female
(110)
Oncology
(98)
Middle Aged
(95)
Aged
(89)
Male
(83)
Biological And Medical Sciences
(75)
Medical Sciences
(72)
Adult
(71)
Chemotherapy
(69)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(64)
Antineoplastic Agents
(46)
Pharmacology. Drug Treatments
(45)
Disease-Free Survival
(37)
Tumors
(37)
Fluorouracil - Administration & Dosage
(35)
Breast Cancer
(33)
Treatment Outcome
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection

Preventing oral mucositis by using its chronology in prior cycle and a special mouthwash

Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

Comparing cancer mortality and GDP health expenditure in England and Wales with other major developed countries from 1979 to 2006

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

Longitudinal study of energy and macronutrient intake during the first year following treatment for early stage breast cancer

Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial

Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin

Prospective DPYD testing in colorectal cancer patients in a realworld UK population

Postoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin benefit in stage II colon cancer (CC): Post hoc analysis of the MOSAIC trial

Glucose Intolerance During Adjuvant Chemotherapy for Breast Cancer

Modulation of platelet levels by an anti-IL-1α antibody (MABp1) in advanced colorectal cancer patients

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF

A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

The impact of primary tumour origins in patients with advanced oesophageal, oesophago–gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four randomised controlled trials

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

Suchergebnisse filtern